Routinely diagnosed simple solid carcinoma (SSC) of the canine mammary gland comprises a heterogeneous group of tumors. Seventy-two cases that had been diagnosed as SSC based on hematoxylin and eosin–stained tissue sections were reclassified immunohistochemically on the basis of myoepithelial markers p63 and α-smooth muscle actin, as well as a luminal epithelial marker cytokeratin 8. Only 23 cases (32%) were true SSC, composed only of luminal epithelial cells, whereas 11 cases (15%) were malignant myoepithelioma (MM), composed predominantly of myoepithelial cells, and 38 cases (53%) were biphasic carcinoma (BC), characterized by biphasic proliferation of luminal epithelial and basal/myoepithelial components. As the pathological parameters were compared between the reclassified tumor types, infiltrative potential, vascular/lymphatic invasion, lymph node metastasis, and Ki-67 labeling index were higher in true SSC compared with MM and BC, suggesting that the former may exhibit a poorer prognosis compared with the latter two.
2 November 2017 in Bioscience, Biotechnology, and Biochemistry
Superantigens (SAgs) are powerful T-cell stimulatory proteins. Because an atopic dermatitis (AD) model NC/Nga mice had two endogenous SAgs, namely minor lymphocyte-stimulating locus-1a (Mls-1a) and mouse mammary tumor virus (MMTV)(SHN), SAg-responsive T-cells bearing Vβ5.1, Vβ6, Vβ8.1, Vβ8.2, Vβ8.3, Vβ9, and Vβ11 should be endogenously deleted. Here, we discuss that the endogenous SAgs-expression may be involved in AD-sensitivity in NC/Nga mice.
1 January 2013 in Japanese Journal of Zoo and Wildlife Medicine
Background: Atopic dermatitis (AD) causes the impact of sleep disorders due to “itching,” is of real harm to society. Recently, the concept of ”gut-skin axis” has gained recognition, however it is still unclear enough. No previous studies had examined whether colitis induce to AD. The aim of this study is therefore to develop the ”gut-skin axis” model such as that colitis induces AD and to explore a treatment for AD by improving gut dysbiosis by using this model. Methods: We used NC/Nga mice with skin barrier fragility, caused the dextran sulfate sodium (DSS)-induced colitis, performed oral treatment of pasteurized Limosilactobacillus reuteri for improving the gut dysbiosis. Result: We found on high sensitivity to DSS-induced colitis in NC/Nga mice. Some months after DSS-induced colitis, AD lesions with “itching” developed spontaneously on bilateral symmetric specific sites, indicating enhanced blood immunoglobulin E and basophils, elevated T-cell helper 17/T-cell regulatory ratio, increased group 2 innate lymphoid cells in enlarged lymph nodes, and increased cutaneous mast cells. Interleukin (IL)-33 enhanced in gut dysbiosis implicated “itching” due to histamine from cutaneous mast cells. In study for a therapy, oral treating pasteurized L. reuteri -solution improved gut dysbiosis and restored AD exacerbated with high IL-33. That indicates protein(s) secreted when L. reuteri die might be a therapeutic target for AD. Conclusions: We found that NC/Nga mice with DSS-induced colitis eventually developed AD without requiring allergens, also identified several gut bacteria related to AD onset and exacerbation, furthermore, showed that improving gut dysbiosis by using pasteurized L.reuteri -solution prevents and cures AD.